- Home
- CATX vs PDT Comparison
CATX vs PDT Comparison
Compare CATX & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- PDT
- Stock Information
- Founded
- CATX 1983
- PDT 1989
- Country
- CATX United States
- PDT United States
- Employees
- CATX N/A
- PDT N/A
- Industry
- CATX Medical/Dental Instruments
- PDT Finance Companies
- Sector
- CATX Health Care
- PDT Finance
- Exchange
- CATX Nasdaq
- PDT Nasdaq
- Market Cap
- CATX 782.7M
- PDT 648.3M
- IPO Year
- CATX N/A
- PDT N/A
- Fundamental
- Price
- CATX $7.88
- PDT $12.69
- Analyst Decision
- CATX Strong Buy
- PDT
- Analyst Count
- CATX 9
- PDT 0
- Target Price
- CATX $21.63
- PDT N/A
- AVG Volume (30 Days)
- CATX 737.4K
- PDT 145.6K
- Earning Date
- CATX 11-12-2024
- PDT 01-01-0001
- Dividend Yield
- CATX N/A
- PDT 8.88%
- EPS Growth
- CATX N/A
- PDT N/A
- EPS
- CATX N/A
- PDT N/A
- Revenue
- CATX $1,557,000.00
- PDT N/A
- Revenue This Year
- CATX N/A
- PDT N/A
- Revenue Next Year
- CATX N/A
- PDT N/A
- P/E Ratio
- CATX N/A
- PDT N/A
- Revenue Growth
- CATX N/A
- PDT N/A
- 52 Week Low
- CATX $2.30
- PDT $8.77
- 52 Week High
- CATX $19.10
- PDT $13.05
- Technical
- Relative Strength Index (RSI)
- CATX 19.19
- PDT 40.22
- Support Level
- CATX $11.40
- PDT $12.70
- Resistance Level
- CATX $12.82
- PDT $13.24
- Average True Range (ATR)
- CATX 0.73
- PDT 0.23
- MACD
- CATX -0.35
- PDT -0.02
- Stochastic Oscillator
- CATX 0.10
- PDT 16.67
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund II is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, and short-term investments.